论文部分内容阅读
目的:观察“三合一”疗法在慢性乙型肝炎治疗中的疗效与病毒载量、ALT水平的关系。方法:给予“三合一”疗法,包括:内服系列中药(肝饮Ⅰ号、肝饮Ⅱ号)12周,随访12周;中药“扶正拔毒膏”膏剂穴位贴敷;理疗离子导入。结果:应答组治疗前HBVDNA水平显著低于无应答组,治疗前ALT水平及治疗过程中ALT升高程度显著高于无应答组,差异均有统计学意义(P<0.05)。结论:中药“三合一”疗法在慢性乙型肝炎治疗中与病毒载量、ALT水平有密切关系。
Objective: To observe the efficacy of “triple therapy” in the treatment of chronic hepatitis B and the relationship between viral load and ALT level. Methods: Give “three in one” therapy, including: oral administration of traditional Chinese medicine (liver Yin Ⅰ, liver Yin Ⅱ) for 12 weeks, followed up for 12 weeks; Chinese medicine “ Ion introduction. Results: The level of HBVDNA in response group before treatment was significantly lower than that in non-response group. The level of ALT before treatment and ALT level in treatment group were significantly higher than those in non-response group (P <0.05). Conclusion: Traditional Chinese medicine ”triple therapy" is closely related to viral load and ALT level in the treatment of chronic hepatitis B patients.